Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Ann Surg Oncol. 2018 Jun 4;25(8):2308–2315. doi: 10.1245/s10434-018-6546-y

TABLE 3.

Summary of pathologic parameters

Variable AdEBR (n = 68) n (%) Ad (n = 99) n (%)
Median tumor size: cm (IQR) 13(11–17.3) 10 (6.5–13)
T stage
 T1 1 (1.5%) 10 (10.1%)
 T2 22 (32.4%) 49 (49.5%)
 T3 29 (42.6%) 32 (32.3%)
 T4 14 (20.6%) 3 (3.0%)
LN dissection
 No 40 (58.8%) 81 (81.8%)
 Yes 25 (36.8%) 12 (12.1%)
N stage
 N0 21 (30.9%) 11 (11.1%)
 N1 11 (16.2%) 5 (5.1%)
 Nx 36 (52.9%) 81 (81.8%)
Mean number of LNs removed (95% CI) 3.4 (2.03–4.83) 0.63 (0.13–1.12)
Grade
 G1 0 (0.0%) 2 (2.0%)
 G2 1 (1.5%) 2 (2.0%)
 G3 6 (8.8%) 9 (9.1%)
 G4 10 (14.7%) 4 (4.0%)
Venous invasion on final pathology
 No 15 (22.1%) 15 (15.2%)
 Yes 15 (22.1%) 11 (11.1%)
Margin status
 R0 46 (67.6%) 66 (66.7%)
 R1 15 (22.1%) 21 (21.2%)
 R2 3 (4.4%) 2 (2.0%)

Data presented in the table reflect all available data from our collaborative database. Percentages may not add up to 100.0% because data were missing for some variables

AdEBR adrenalectomy with en bloc resection, Ad adrenalectomy with no en bloc resection, IQR interquartile range, LN lymph node, CI confidence interval